The aim of this study was to investigate the impact of SUVmax fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) measured in the primary tumor, pelvic and para-aortic node with disease-free survival (DFS) and overall survival (OS) in patients with locally advanced cervical cancer.
Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer / Cima, Simona; Perrone, Anna Myriam; Castellucci, Paolo; Macchia, Gabriella; Buwenge, Milly; Cammelli, Silvia; Cilla, Savino; Ferioli, Martina; Ferrandina, Gabriella; Galuppi, Andrea; Salizzoni, Eugenio; Rubino, Daniela; Fanti, Stefano; De Iaco, Pierandrea; Morganti, Alessio Giuseppe. - In: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. - ISSN 1048-891X. - ELETTRONICO. - 28:3(2018), pp. 575-580. [10.1097/IGC.0000000000001207]
Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer
Cima, Simona;Perrone, Anna Myriam;Castellucci, Paolo;Buwenge, Milly;Cammelli, Silvia;FERIOLI, MARTINA;Galuppi, Andrea;Salizzoni, Eugenio;Rubino, Daniela;Fanti, Stefano;De Iaco, Pierandrea;Morganti, Alessio Giuseppe
2018
Abstract
The aim of this study was to investigate the impact of SUVmax fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) measured in the primary tumor, pelvic and para-aortic node with disease-free survival (DFS) and overall survival (OS) in patients with locally advanced cervical cancer.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
